Tivic reports second quarter 2024 financial results

San francisco--(business wire)--tivic health® systems, inc. (“tivic”, nasdaq: tivc), a health tech company that develops and commercializes bioelectronic medicine, today announced its second quarter 2024 financial results and discussed growth strategies based on its investments in vagus nerve stimulation ("vns"). “this quarter is the start of a potentially transformational period for tivic. we announced the results of our successful phase 1 trial of a new approach to non-invasive vagus nerve st.
TIVC Ratings Summary
TIVC Quant Ranking